July 2016 Newsletter

July 25, 2016:

FDA Issues Five Ophthalmic Approvals in Less than Month

Three approvals were for new products, including Shire’s dry eye treatment.

July 25, 2016:

XEN, CyPass Poised to Spur Fast-Growing MIGS Market for Glaucoma

Both implants are in the final stages of FDA review.

July 25, 2016:

New Report Highlights ‘Visual Health Crisis’ in China

Country faces myopia rate of more than 50 percent in four years, based on current trends.

July 25, 2016:

Santen to Acquire InnFocus, Maker of MicroShunt Implant for Glaucoma

Deal calls for $225 million up front, plus milestone payments.

July 25, 2016:

OCTANe Attracts Record Participation for Third Annual Meeting

California accelerator outgrows conference venue and promises larger space in 2017.

July 25, 2016:

FDA Approval of Abbott’s TECNIS Symfony to Expand Demand for PC-IOLs

The lens was launched at the 2014 ESCRS convention, and its popularity has grown.

July 25, 2016:

Shire’s Xiidra is First US Prescription Drug for Dry Eye Signs, Symptoms

Allergan’s Restasis, previously the only prescription dry eye drug in the US, posted revenues of more than $1 billion in 2015.

July 25, 2016:

ReVision Optics Receives FDA Approval for Raindrop Near Vision Inlay

The company plans to launch the device in Q3-2016.

July 25, 2016:

AbbVie’s Humira Gains Indication in US for Noninfectious Uveitis

The drug was first approved in the US in 2003 for rheumatoid arthritis and has been used to treat more than 989 thousand patients worldwide, the company said.

July 25, 2016:

Avedro’s Crosslinking Technology Receives FDA Labeling for Corneal Ectasia

The platform was approved in April for treatment of progressive keratoconus.

July 25, 2016:

RoundTable to Sell Beaver-Visitec to TPG Capital

Waltham, MA-based BVI makes ophthalmic surgical instruments for cataract, refractive, oculoplastic, and vitreoretinal procedures.

July 25, 2016:

ASC Operator AmSurg to Merge with Envision Healthcare

The combined company, to be named Envision Healthcare Corporation, will have a market cap of about $10 billion

July 25, 2016:

Wrobel to Leave Retina Implant AG

Longtime board member Reinhard Rubow will become executive director.

July 25, 2016:

John Sheets, PhD, Appointed Chief Scientific Officer of FDA Office of Device Evaluation

Ophthalmic industry veteran started in the role June 12.

July 25, 2016:

FDA Seeks New Consumer Rep for Ophthalmic Devices Advisory Panel

Nominees may be submitted through Aug. 31.

July 25, 2016:

Five Ophthalmic Products in Final Stages of FDA Review

Alcon’s AcrySof IQ ReSTOR multifocal toric lens has been waiting the longest, receiving the backing of an FDA advisory panel in November 2014.

July 25, 2016:

FDA Seeks More Info on B+L’s Vesneo as Glaucoma Treatment

Manufacturing deficiencies were the focus of concerns, not the performance of the drug.

July 25, 2016:

CMS Silent on Office-Based Cataract Surgery in Proposed Fees for 2017

Trade group representing ASCs said it hopes health officials have dropped the idea.

July 25, 2016:

Study: Five-Year Results Confirm Safety, Effectiveness of Argus II Retinal Prosthesis

Twenty-four of 30 patients had functioning implants midway through the 10-year trial.

July 25, 2016:

2020 On-Site Optometry Raises $3 Million in Additional Funding, Expands Rapidly

Boston startup said it will add service this fall in Chicago.

July 25, 2016:

Google’s DeepMind, MoorFields to Use Artificial Intelligence in Eye Care

The partnership was announced July 5, shortly after IBM Watson unveiled its own AI project in eye care.

July 25, 2016:

LASIK Surgeon Robert Arffa Dies in Plane Crash

The Pennsylvania ophthalmologist was making a monthly trip to State College to perform surgery.

July 25, 2016:

July 2016 News Briefs

Social media